Essentia Health in Duluth now has a new tool to help diagnose Alzheimer’s, and it’s the first of its kind in the Northland. The amyloid PET Scan machine helps detect signs of the plaques that build up ...

January 18, 2011 — Findings on positron emission tomography (PET) using the radiotracer florbetapir F 18 correlate with the presence and quantity of brain β-amyloid pathology found at autopsy, a new ...

A research group has investigated how Alzheimer's disease can be diagnosed more reliably in the future. A research group at LMU University Hospital has investigated how Alzheimer's disease can be ...

Findings showed 91.7% of patients with positive results using Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test had amyloid plaques based on PET scan or CSF test results. The Food and Drug ...

Quantification of amyloid beta neuritic plaque levels can now be used in conjunction with visual assessment in the updated label. The Food and Drug Administration (FDA) has approved an updated label ...

Share on Pinterest A new study suggests that PET brain scans could help identify individuals at risk of cognitive decline, allowing them to receive earlier intervention. Reza Estakhrian/Getty Images ...

Tau PET has become a valuable research tool, but questions remain about how well tracer uptake reflects underlying tangles, how plaques influence this relationship, and how effectively the scans could ...

The FDA has approved the first blood test to detect signs of Alzheimer’s disease, marking a major step toward easier diagnosis. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test identifies ...

Mounting evidence links infections to a greater risk of dementia, and vaccination to neuroprotection. What underlies this relationship? In a preprint posted to Research Square on January 13, ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss? That’s the potential promise of a new class of biomark ...